Abstract:Currently, conjugation of artemisinin-derived dimers, trimers, and tetramers is a viable strategy for developing new effective antimalarial candidates. Furthermore, nanotechnology is an effective means to achieve intravenous administration of hydrophobic drugs. In this paper, an ester-linked dihydroartemisinin trimer (DHA3) was synthesized and further prepared as self-assembled nanoparticles (DHA3NPs) by a one-step nanoprecipitation method. The pharmacokinetics and antimalarial pharmacodynamics of DHA3NPs were studied in rats and mice infected with Plasmodium yoelii BY265 (PyBY265). DHA3NPs had a regular spherical shape with a uniform size distribution of 140.27 ± 3.59 nm, entrapment efficiency (EE) of 99.63 ± 0.17%, and drug loading efficiency (DL) of 79.62 ± 0.11%. The in vitro release characterization revealed that DHA3NPs were easily hydrolysed into DHA in an esterase environment. The pharmacokinetics study demonstrated that the area under the concentration–time curve (AUC0-t) of DHA in DHA3NPs group was 2070.52 ± 578.76 h×ng×mL−1, which was higher than that of DHA and artesunate (AS) control groups (AUC0-t values of 724.18 ± 94.32 and 448.40 ± 94.45 h×ng×mL−1, respectively) (P < 0.05). The antimalarial pharmacodynamics in vivo suggested that DHA3NPS (ED90 7.82 ± 1.16 μmol×(kg×day)−1) had a superior antimalarial effect compared with that of control groups (ED90 values of 14.68 ± 0.98 (DHA) and 14.34 ± 1.96 (AS) μmol×(kg×day)−1) (P < 0.05). In addition, DHA3NPS reduced the recurrence ratio and improved the cure ratio and survival time. In summary, DHA3NPs exhibited promising pharmacokinetic characteristics and antimalarial pharmacodynamics in vivo.

Dihydroartemisinin Loaded Nanostructured Lipid Carriers (DHA-NLC): Evaluation of Pharmacokinetics and Tissue Distribution after Intravenous Administration to Rats.

Antitumor effects of the nanostructured lipid carriers of dihydroartemisinin

Liquid Chromatography-Tandem Mass Spectrometry Assay for the Quantitation of Beta-Dihydroartemisinin in Rat Plasma

LC–HRMS methods for the quantification of two artemisinin drugs and their metabolites in rat blood and plasma

Formulation Optimization of Dihydroartemisinin Nanostructured Lipid Carrier Using Response Surface Methodology

Murine pharmacokinetics and antimalarial pharmacodynamics of dihydroartemisinin trimer self-assembled nanoparticles

Biodegradable Iron-Coordinated Hollow Polydopamine Nanospheres For Dihydroartemisinin Delivery And Selectively Enhanced Therapy In Tumor Cells

Encapsulation of Low Lipophilic and Slightly Water-Soluble Dihydroartemisinin in PLGA Nanoparticles with Phospholipid to Enhance Encapsulation Efficiency and in Vitro Bioactivity.

In Vivo Biodistribution, Anti-Inflammatory, and Hepatoprotective Effects of Liver Targeting Dexamethasone Acetate Loaded Nanostructured Lipid Carrier System

Dihydroartemisinin Exhibits Antitumor Activity Toward Hepatocellular Carcinoma in Vitro and in Vivo.

Study on the Method ology of Transdermal Experiments in Vitro of Transdermal Drug Delivery of Dihydroartemisinin

Assessing the safety of transarterial locoregional delivery of low-density lipoprotein docosahexaenoic acid nanoparticles to the rat liver

The Multiple-Dosing Pharmacokinetics of Artemether, Artesunate, and Their Metabolite Dihydroartemisinin in Rats.

Quantitative Analysis of Artemether and its Metabolite Dihydroartemisinin in Human Plasma by LC with Tandem Mass Spectrometry

Synthesis and Preliminary Antitumor Activity Evaluation of Docosahexaenoic Acid-Dihydroartemisinin Conjugate

Semi-synthetic product dihydroartemisinin inhibited fibronectin-1 and integrin-β1 and interfered with the migration of HCCLM6 cells via PI3K-AKT pathway

Application of LC-MS/MS method for determination of dihydroartemisin in human plasma in a pharmacokinetic study

Determination of artemether and its metabolite dihydroartemisinin in human plasma by HPLC with atmospheric pressure chemical ionization mass spectrometry

Development of an LC-MS/MS-based assay to determine Artemitin in rat plasma and its application in a pharmacokinetic study.

Magnetic Double Hydrogen Artesunate Nano Liposome on CAL Tongue Squamous Carcinoma and Laryngeal Hep-2-27 Cell Lines: An In Vitro Study

Development and Validation of a Highly Sensitive LC-MS/MS Method for Determination of Brain Active Agent Dianhydrogalactitol in Mouse Plasma and Tissues: Application to a Pharmacokinetic Study.